Harald Stein

Q: What Schools Are Affiliated With Harald Stein

Harald Stein is affiliated with the following schools: Leipzig University, University of Cambridge, Medical University of Vienna, Humboldt University of Berlin, University of Oxford, University of Siena

Harald Stein's AcademicInfluence.com Rankings

Harald Stein

Medical

#692

World Rank

#918

Historical Rank

Hematology

World Rank

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Harald Stein Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Harald Stein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. (1994) (6264)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms. (2016) (5445)
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. (1984) (4207)
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). (1984) (3311)
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation (1983) (2726)
The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. (1985) (1836)
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. (2011) (1782)
Oncogene-induced senescence as an initial barrier in lymphoma development (2005) (1182)
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. (2006) (966)
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. (2000) (841)
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. (1997) (776)
Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease (1992) (665)
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases (2002) (586)
The Histopathology of Malignant Lymphoma (1975) (521)
Mantle Cell Lymphoma A Proposal for Unification of Morphologic, Immunologic, and Molecular Data (1992) (516)
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. (2013) (487)
Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. (2000) (475)
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. (2000) (462)
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. (2015) (454)
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. (1995) (448)
Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. (1989) (440)
Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. (1991) (410)
Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level. (2006) (409)
Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. (2002) (405)
Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. (1998) (402)
Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas. (1980) (395)
Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. (1990) (370)
Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. (2008) (367)
Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB (2002) (367)
The normal and malignant germinal centre. (1982) (350)
Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. (1988) (344)
MALIGNANT HISTIOCYTOSIS OF THE INTESTINE: A T-CELL LYMPHOMA (1985) (343)
Cytological and functional criteria for the classification of malignant lymphomata. (1975) (338)
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. (2009) (333)
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network (2005) (318)
Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki‐67 (1984) (314)
BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. (1989) (312)
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma (2010) (310)
Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. (1997) (299)
In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: Evidence for predominant expression in nonparenchymal liver cells (1989) (291)
Nuclear Factor κB–dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity (2002) (286)
Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. (1999) (284)
HUMAN LYMPHOID CELLS EXPRESS EPITHELIAL MEMBRANE ANTIGEN Implications for Diagnosis of Human Neoplasms (1984) (280)
Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. (1984) (280)
Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. (2001) (272)
Monoclonal antibodies OKT 11 and OKT 11A have pan‐T reactivity and block sheep erythrocyte “receptors” (1982) (266)
Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. (1995) (262)
Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. (1991) (262)
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. (2006) (251)
Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. (1986) (247)
Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. (1983) (246)
Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. (1992) (240)
Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. (2003) (238)
Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. (2006) (231)
High incidence of Epstein-Barr virus genomes in Hodgkin's disease. (1990) (229)
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy (1982) (227)
Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. (1996) (221)
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. (2011) (221)
Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin (1992) (218)
c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis (2004) (217)
Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. (1985) (214)
Hodgkin's lymphoma: the pathologist's viewpoint. (2002) (214)
Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. (2004) (212)
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. (2010) (209)
Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. (1989) (208)
Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. (1991) (207)
Novel markers of normal and neoplastic human plasmacytoid dendritic cells. (2008) (207)
Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival (2007) (204)
Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. (2000) (204)
Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics. (1989) (199)
CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. (1991) (198)
Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. (1996) (198)
Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. (1994) (198)
Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma (2006) (196)
The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia. (1985) (195)
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation. (2007) (194)
Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. (1999) (194)
Monoclonal Antibodies in the Diagnosis of Hodgkin's Disease: The Search for a Rational Panel (1988) (194)
Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. (1995) (193)
Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. (1990) (190)
Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. (1992) (189)
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL. (2010) (189)
REARRANGEMENT OF THE T-CELL-RECEPTOR β-CHAIN GENE IN THE DIAGNOSIS OF LYMPHOPROLIFERATIVE DISORDERS (1985) (188)
Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. (1993) (183)
Epstein–Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus (1991) (179)
Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. (1986) (178)
Lymphohistiocytic T‐cell lymphoma (anaplastic large cell lymphoma CD30+/Ki‐1 + with a high content of reactive histiocytes) (1990) (176)
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group. (2017) (175)
Cellular localization of type I III and IV procollagen gene transcripts in normal and fibrotic human liver. (1990) (175)
Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. (1992) (175)
Expression of vascular endothelial growth factor in lymphomas and castleman's disease (1997) (173)
Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis (2006) (170)
Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma (2003) (168)
Series THE UPDATED WHO CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES The 2016 revision of the World Health Organization classi fi cation of lymphoid neoplasms (2016) (166)
Lymphoblastic lymphoma of convoluted or acid phosphatase type‐A tumor of T precursor cells (1976) (165)
Hodgkin and sternberg‐reed cells contain antigens specific to late cells of granulopoiesis (1982) (165)
Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease. (2003) (165)
Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. (1986) (164)
Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. (2006) (164)
Evaluation of endosonography in TN staging of oesophageal cancer. (1991) (160)
Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network (2009) (159)
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma (2014) (159)
Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease (1999) (158)
Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. (2010) (157)
CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. (1995) (157)
Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. (1999) (155)
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. (2005) (154)
T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. (1999) (151)
Ki‐1 (CD30) antigen is released by Ki‐1‐positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki‐1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme‐linked immunosorbent assay (1989) (151)
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. (2009) (151)
Inactivating I kappa B epsilon mutations in Hodgkin/Reed–Sternberg cells (2003) (151)
Immunohistology and aetiology of histiocytic necrotizing lymphadenitis. Report of three instructive cases (1983) (149)
The HML-1 antigen of intestinal lymphocytes is an activation antigen. (1990) (149)
Ocular adnexal lymphomas: five case presentations and a review of the literature. (2002) (148)
Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. (1986) (148)
Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. (2006) (146)
Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary (1997) (145)
Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue (2001) (145)
Double Immunoenzymatic Labelling (1983) (145)
Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome (2003) (143)
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). (2013) (142)
A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms (2009) (139)
High serum level of the soluble form of CD30 molecule in the early phase of HIV‐1 infection as an independent predictor of progression to AIDS (1994) (137)
Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. (1999) (136)
Telomerase as a prognostic marker in breast cancer: high‐throughput tissue microarray analysis of hTERT and hTR (2002) (135)
Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes. (1994) (132)
The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen (1994) (131)
Human dendritic reticulum cells of lymphoid follicles: Their antigenic profile and their identification as multinucleated giant cells (1983) (131)
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas (2007) (130)
Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell. (1983) (130)
Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. (1991) (129)
Expression of MUC2‐mucin in colorectal adenomas and carcinomas of different histological types (1994) (126)
Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. (1989) (125)
PROGNOSTIC RELEVANCE OF TUMOUR-CELL GROWTH FRACTION IN MALIGNANT NON-HODGKIN'S LYMPHOMAS (1987) (124)
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness (2008) (123)
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer (2006) (123)
Genotypic analysis of large cell lymphomas which express the Ki‐1 antigen (1987) (122)
Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. (2002) (121)
Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. (1992) (121)
The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. (1991) (121)
High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. (2000) (119)
EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products (1992) (119)
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. (2008) (118)
Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. (1993) (118)
Epstein‐Barr virus in B‐cell non‐Hodgkin's lymphomas: Unexpected infection patterns and different infection incidence in low‐ and high‐grade types (1995) (118)
Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. (2004) (116)
Anaplastic large cell lymphoma (CD30+/Ki‐1+): results of a prospective clinico‐pathological study of 69 cases (1994) (116)
Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody. (1987) (115)
Clonal T‐cell receptor γ‐chain gene rearrangement by PCR‐based GeneScan analysis in advanced cutaneous T‐cell lymphoma: a critical evaluation (1999) (115)
Cellular localization of procollagen gene transcripts in inflammatory bowel diseases. (1992) (114)
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma (2011) (113)
Human complement (C3b) receptors defined by a mouse monoclonal antibody. (1982) (111)
Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors (2002) (111)
Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas (2005) (111)
Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. (1990) (111)
Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. (1995) (111)
New approach to assessing lung tumours in man. (1986) (111)
Co‐expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma (1998) (110)
Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases (2004) (109)
Expression of the CD30 antigen in non‐lymphoid tissues and cells (2000) (107)
Malignant lymphomas of B-cell type. (1972) (107)
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. (1996) (107)
Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen. (1991) (107)
Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. (1989) (106)
MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. (1997) (106)
Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. (2002) (105)
Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer. (2001) (105)
Expression of lymphoid‐associated antigens on Hodgkin's and Reed‐Sternberg cells of Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies (1987) (105)
Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma (2009) (103)
The complexity of immunohistochemical staining pattern of hodgkin and sternberg‐reed cells—demonstration of immunoglobulin, albumin, α1‐antichymotrypsin and lysozyme (1978) (103)
Patterns of cytokine gene expression in infectious mononucleosis. (1994) (101)
New approaches to lymphoma diagnosis. (2001) (101)
Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines. (1987) (100)
The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma (2000) (100)
Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Comparison with large plaque parapsoriasis and benign chronic dermatoses. (1985) (97)
Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases (2002) (97)
Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals. (1997) (96)
Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. (1994) (96)
Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum (2002) (96)
Lymphotoxin, tumour necrosis factor and interleukin‐6 gene transcripts are present in Hodgkin and Reed‐Sternberg cells of most Hodgkin's disease cases (1993) (96)
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation (2010) (95)
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha. (2008) (95)
The value of immunohistological screening in the production of monoclonal antibodies. (1982) (94)
Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells. (1999) (93)
Clonal T cell receptor γ‐chain gene rearrangement by PCR‐based GeneScan analysis in the skin and blood of patients with parapsoriasis and early‐stage mycosis fungoides (2002) (93)
Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes). (1980) (92)
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo. (2007) (92)
FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas (1999) (91)
Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia (2000) (91)
Ber-EP 4 : new monoclonal antibody which distinguishes epithelia from mesothelia (91)
Neuroendocrine differentiation is a relevant prognostic factor in stage III–IV colorectal cancer (2001) (90)
The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies. (1984) (90)
Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells. (2006) (90)
Clinicopathological Consultation Aids-Related Plasmablastic Lymphomas of the Oral Cavity and Jaws: A Diagnostic Dilemma (1999) (90)
CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule. (1995) (89)
Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. (2004) (89)
A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group) (1994) (88)
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas (2012) (88)
Attempts to demonstrate virus‐specific sequences in human tumors. IV. EB viral DNA in European burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis (1976) (88)
Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy. (1986) (86)
An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel (1984) (86)
Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil. (1996) (85)
Ber‐H2 (anti‐CD30)‐saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation (1992) (84)
Primary intraocular lymphoma of T-cell type: report of a case and review of the literature (2005) (83)
Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. (1986) (83)
The prognostic significance of epithelial-mesenchymal transition in breast cancer. (2002) (83)
Isolation of follicular dendritic cells from human tonsils and adenoids. II. Immunocytochemical characterization (1984) (82)
[Telomerase as a tumor marker?]. (1997) (82)
Intraocular lymphoma 2000–2005: results of a retrospective multicentre trial (2006) (82)
Evidence for the detection of the normal counterpart of hodgkin and sternberg‐reed cells (2007) (82)
Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies. (1990) (82)
Differential Eµ enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B‐cell populations, B‐cell non‐Hodgkin lymphomas, and Hodgkin lymphomas (2004) (82)
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma (2019) (81)
Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece (2006) (80)
ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. (1995) (80)
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children (2011) (79)
Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. (2006) (79)
Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes. (2006) (78)
Microarray‐based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status (2009) (77)
Tumor cell growth fraction in Hodgkin's disease. (1987) (77)
Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. (2005) (76)
Detection of genomic aberrations in molecularly defined Burkitt’s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis (2010) (76)
Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver (1991) (76)
Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma (1998) (76)
Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences (2004) (74)
Early TCR-β and TCR-γ PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications (2005) (74)
Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. (2001) (73)
Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. (2002) (73)
Immature sinus histiocytes. Their identification as a novel B-cell population. (1984) (72)
Monocytoid B cells are distinct from splenic marginal zone cells and commonly derive from unmutated naive B cells and less frequently from postgerminal center B cells by polyclonal transformation. (1999) (72)
Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis (2006) (72)
Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma (2008) (71)
Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type. (1997) (71)
Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin. (2002) (71)
HML-1 antigen on mucosa-associated T cells, activated cells, and hairy leukemic cells is a new integrin containing the beta 7 subunit. (1991) (70)
Analysis of p53/BAX in primary colorectal carcinoma: Low BAX protein expression is a negative prognostic factor in UICC stage III tumors (2002) (69)
Epstein-Barr virus and CD30+ malignant lymphomas. (1993) (69)
Cellular origin and clonality of classic Hodgkin's lymphoma: immunophenotypic and molecular studies. (1999) (69)
EXPRESSION OF T-CELL-RECEPTOR β CHAIN IN REED-STERNBERG CELLS (1989) (66)
Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies. (1987) (66)
Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. (2005) (66)
CCR7 deficiency causes ectopic lymphoid neogenesis and disturbed mucosal tissue integrity. (2007) (66)
International study on low‐grade primary central nervous system lymphoma (2006) (66)
Cellular localization of laminin gene transcripts in normal and fibrotic human liver. (1989) (65)
Demonstration of lysozyme, α1-antichymotrypsin, α1-antitrypsin, albumin, and transferrin with the immunoperoxidase method in lymph node cells (1980) (65)
Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa. (1999) (65)
Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma. (1995) (65)
Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease. (1995) (65)
Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. (1995) (65)
Detection of HTLV-I proviral sequences in CD30-positive large cell cutaneous T-cell lymphomas. (1990) (64)
Activated Notch 1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma (2002) (63)
Evolutionary conservation in various mammalian species of the human proliferation-associated epitope recognized by the Ki-67 monoclonal antibody. (1989) (63)
Phenotypic analysis of an established cell line derived from a patient with Hodgkin's disease (HD) (1985) (62)
Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing. (1991) (62)
High proliferative activity of Reed Sternberg associated antigen Ki-1 positive cells in normal lymphoid tissue. (1986) (62)
Epstein‐Barr Virus and Carcinomas Expression of the Viral Genome in an Undifferentiated Gastric Carcinoma (1992) (62)
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma (2015) (62)
CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells. (2008) (62)
Surface immunoglobulins and lymphocyte-specific surface antigens on leukaemic reticuloendotheliosis cells. (1974) (60)
So-called fibroepithelial polyps of the vagina exhibiting an unusual but uniform antigen profile characterized by expression of desmin and steroid hormone receptors but no muscle-specific actin or macrophage markers. (1990) (60)
MONOKINE EXPRESSION IN LANGERHANS' CELL HISTIOCYTOSIS AND SINUS HISTIOCYTOSIS WITH MASSIVE LYMPHADENOPATHY (ROSAI–DORFMAN DISEASE) (1996) (60)
CD 30 1 anaplastic large cell lymphoma : a review of its histopathologic , genetic , and clinical features (2000) (60)
Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review. (1995) (60)
TP53 mutation and survival in aggressive B cell lymphoma (2017) (60)
CELL LINEAGE IN HODGKIN'S DISEASE (1987) (59)
Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage. (1990) (59)
Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer (2009) (59)
Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis – a consensus‐based study (2016) (58)
Undulin is a novel member of the fibronectin-tenascin family of extracellular matrix glycoproteins. (1991) (58)
Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo. (1993) (58)
Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group. (2007) (58)
Frequent expansion of Epstein–Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV‐associated lymphoma (1999) (57)
Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. (1995) (57)
Carbohydrate Recognition on MUC1‐Expressing Targets Enhances Cytotoxicity of a T Cell Subpopulation (1997) (57)
Presence of α1-Antichymotrypsin and α1-Antitrypsin in Haematopoietic and Lymphoid Tissue Cells as Revealed by the Immunoperoxidase Method (1980) (57)
Lymphoma classification proposal: clarification. (1995) (57)
Expression of the human OX40 (hOX40) antigen in normal and neoplastic tissues (1995) (56)
In vivo targeting of Hodgkin and Reed‐Sternberg cells of Hodgkin's disease with monoclonal antibody Ber‐H2 (CD30): immimohistological evidence (1992) (56)
Low incidence of Epstein–Barr virus presence in primary cutaneous T‐cell lymphoproliferations (1996) (55)
Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis (2003) (55)
Complement (C3) receptors on dendritic reticulum cells of normal and malignant lymphoid tissue. (1982) (55)
Detection of cytomegalovirus by in situ hybridisation and immunohistochemistry using new monoclonal antibody CCH2: a comparison of methods. (1988) (55)
Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation (2003) (55)
WHO ) classification of lymphoid neoplasms (2016) (54)
Simultaneous flow cytometric analysis of surface markers and nuclear Ki-67 antigen in leukemia and lymphoma. (1989) (53)
Serum levels of soluble CD30 molecule (Ki‐1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage (1990) (53)
Simultaneous Presence of Receptors for Complement and Sheep Red Blood Cells on Human Fetal Thymocytes (1977) (53)
Lymphomatoid papulosis followed by large‐cell lymphoma: immunophenotypical and genotypical analysis (1991) (53)
Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans’ cell sarcoma: evidence for hematopoietic plasticity (2010) (53)
Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density. (1996) (53)
Low‐grade primary central nervous system lymphoma in immunocompetent patients (2005) (53)
Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells (1987) (53)
Histiocytic necrotizing lymphadenitis without granulocytic infiltration (Kikuchi's lymphadenitis). Morphological and immunohistochemical study of eight cases (1987) (52)
Telomerase activity in bladder cancer, bladder washings and in urine. (1996) (52)
Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma. (2005) (51)
Autocrine interleukin‐1 receptor antagonist can support malignant growth of glioblastoma by blocking growth‐inhibiting autocrine loop of interleukin‐1 (1997) (51)
Description of a sequential staining procedure for double immunoenzymatic staining of pairs of antigens using monoclonal antibodies. (1986) (51)
Anti‐CD30 (BER‐H2) immunotoxins containing the type‐1 ribosome‐inactivating proteins momordin and PAP‐S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice (1996) (50)
Immunohistochemical determination of growth fractions in human permanent cell lines and lymphoid tumours: a critical comparison of the monoclonal antibodies OKT9 and Ki‐67 (1987) (50)
Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. (2016) (50)
Pathway activation patterns in diffuse large B-cell lymphomas (2008) (50)
Anaplastic large cell lymphoma: update of findings. (1995) (50)
Temporal and spatial patterns of proto-oncogene expression at early stages of toxic liver injury in the rat. (1991) (50)
Isolation and antigenic profile of follicular dendritic cells. (1989) (50)
The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies. (1985) (50)
evolving concepts and practical applications The 2008 WHO classification of lymphoid neoplasms and beyond (2011) (49)
Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma. (2005) (49)
Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67 (2004) (48)
Loss of Nuclear p27 Expression and Its Prognostic Role in Relation to Cyclin E and p53 Mutation in Gastroenteropancreatic Neuroendocrine Tumors (2008) (48)
Complement Receptor Subtypes C3b and C3d in Lymphatic Tissue and Follicular Lymphoma (1978) (48)
Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype (2008) (48)
Screening for oesophageal neoplasia in patients with head and neck cancer (2002) (48)
FREEZE-DRIED PARAFFIN-EMBEDDED HUMAN TISSUE FOR ANTIGEN LABELLING WITH MONOCLONAL ANTIBODIES (1984) (47)
Heterogeneity of bcl‐2 expression in MALT lymphoma (1995) (47)
The expression of the CD3 antigen in Hodgkin's disease (1989) (46)
Ber-ACT8: new monoclonal antibody to the mucosa lymphocyte antigen. (1991) (46)
Influence of antigen on the development of MALT lymphoma. (2006) (46)
Refractory Sprue Syndrome with Clonal Intraepithelial Lymphocytes Evolving into Overt Enteropathy-Type Intestinal T-Cell Lymphoma (2000) (46)
High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas (2010) (46)
Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki‐67 and anti‐bromo‐deoxyuridine monoclonal antibodies (1988) (46)
Detection of a mucin marker for the adenoma-carcinoma sequence inhuman colonic mucosa by monoclonal antibody AM-3. (1990) (46)
Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1. (2004) (46)
Assignment of the human CD30 (Ki-1) gene to 1p36. (1992) (45)
Use of Oxytocin Receptor Expression in Distinguishing Between Uterine Smooth Muscle Tumors and Endometrial Stromal Sarcoma (2003) (45)
Molecular profiles and clinical outcome of stage UICC II colon cancer patients (2011) (45)
Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases (2005) (45)
Hodgkin's disease followed by lymphomatoid papulosis. Immunophenotypic evidence for a close relationship between lymphomatoid papulosis and Hodgkin's disease. (1990) (45)
A case of classical mycosis fungoides associated with human T‐cell lymphotropic virus type I (1991) (45)
T-cell clonality of undetermined significance. (2001) (45)
Genomic loss of the putative tumor suppressor gene E2A in human lymphoma (2011) (44)
The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells (1992) (44)
Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation. (2001) (44)
Langerhans' cells in human cervical epithelium: an immunohistological study. (1984) (44)
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma – analyses of cases from two prospective randomized clinical trials (2009) (43)
Use of a panel of monoclonal antibodies for the diagnosis of hairy cell leukaemia. An immunocytochemical study of 36 cases (1986) (43)
The Immunologic and Immunochemical Basis for the Kiel Classification (1978) (43)
Comparison of Anaplastic Large Cell Ki‐1 Lymphomas and Microvillous Lymphomas in their Immunologic and Ultrastructural Features (1990) (43)
Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas. (1996) (43)
Reactivity of T cells in mycosis fungoides exhibiting marked epidermotropism with the monoclonal antibody HML-1 that defines a membrane molecule on human mucosal lymphocytes. (1989) (43)
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Appropriate for Autologous Stem Cell Transplantation: Results of an Open-Label Phase II Trial. (2004) (43)
Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications. (2005) (43)
Prevention of colitis‐associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid (2006) (42)
The value of lymph node biopsy in patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS‐related complex (ARC): a morphological and immunohistochemical study of 90 cases (1986) (42)
Lymphomatoid papulosis. Characterization of skin infiltrates by monoclonal antibodies. (1985) (42)
Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus (2016) (41)
Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification (2007) (41)
Immunohistological determination of oestrogen receptor, progesterone receptor, and intermediate filaments in Leydig cell tumours, Leydig cell hyperplasia, and normal Leydig cells of the human testis (1989) (40)
Detection of viral DNA by in situ hybridization using bromodeoxyuridine-labeled DNA probes. (1988) (40)
DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas. (2007) (40)
Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma (2008) (40)
Translocations activating IRF 4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults * (2011) (39)
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. (2007) (39)
Nuclear Survivin Is a Powerful Novel Prognostic Marker in Gastroenteropancreatic Neuroendocrine Tumor Disease (2005) (39)
Oral manifestations of AIDS-associated non-Hodgkin's lymphomas. (1991) (39)
Radiologic morphology of low-grade primary central nervous system lymphoma in immunocompetent patients. (2005) (39)
Human papillomavirus infection is not associated with bronchial carcinoma: evaluation by in situ hybridisation and the polymerase chain reaction (1997) (39)
HHV-8-Associated T-Cell Lymphoma in a Lymph Node With Concurrent Peritoneal Effusion in an HIV-Positive Man (2005) (39)
The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil (2006) (39)
Diagnosis of a primary uveal extranodal marginal zone B-cell lymphoma by chorioretinal biopsy: case report (2005) (38)
Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization (1998) (38)
PHENOTYPIC MODULATION OF HODGKIN AND REED–STERNBERG CELLS BY EPSTEIN–BARR VIRUS (1996) (38)
Histology and immunohistology of bone marrow biopsy in multiple myeloma (1989) (38)
Increased serum levels of soluble IL‐2 receptor, CD30 and CD8 molecules, and gamma‐interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms (1990) (38)
T‐cell origin of Lennert's lymphoma (1986) (38)
Disappearance of the Epstein–Barr virus in a relapse of Hodgkin's disease (1997) (37)
Characterization of benign cutaneous lymphocytic infiltrates by monoclonal antibodies (1984) (37)
Diagnostic value of endoscopy for the diagnosis of giardiasis and other intestinal diseases in patients with persistent diarrhea from tropical or subtropical areas (2007) (37)
T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. (2005) (36)
Tumor Stroma-Derived TGF-b Limits Myc-Driven Lymphomagenesis via Suv 39 h 1-Dependent Senescence (2009) (36)
Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma. (2000) (35)
Up-Regulation of the Peripheral Benzodiazepine Receptor during Human Colorectal Carcinogenesis and Tumor Spread (2005) (35)
[Cutaneous B cell lymphoma in chronic Borrelia burgdorferi infection. Report of 2 cases and a review of the literature]. (1988) (35)
Assessment of HOPE fixation in vitrectomy specimens in patients with chronic bilateral uveitis (masquerade syndrome) (2005) (35)
Expression of cytotoxic molecules in intestinal T‐cell lymphomas (1997) (34)
Cultured human NK cells express the Ki‐l/CD30 antigen (1993) (33)
Association of tissue-factor upregulation in squamous-cell carcinoma of the lung with increased tissue factor in circulating blood. (2005) (33)
A modular transcriptome map of mature B cell lymphomas (2019) (33)
cIAP2 is highly expressed in Hodgkin–Reed–Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3 (2006) (33)
An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins. (1999) (33)
Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis (2014) (33)
Epstein-Barr virus in Kikuchi-Fujimoto disease (1993) (32)
Non‐radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine (1998) (32)
Differential expression of TRAF1 aids in the distinction of cutaneous CD30-positive lymphoproliferations. (2007) (32)
Heterogeneous Expression of Neuroendocrine Marker Proteins in Human Undifferentiated Carcinoma of the Colon and Rectum (2004) (31)
Expression of a cell-cycle-associated nuclear antigen (Ki-67) in cutaneous lymphoid infiltrates. (1986) (31)
Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease. (2004) (31)
Histopathological features and their prognostic impact in nodular lymphocyte‐predominant Hodgkin lymphoma – a matched pair analysis from the German Hodgkin Study Group (GHSG) (2014) (31)
Monoclonal antibody patterns in lymphomatoid papulosis. (1985) (30)
Paraffin section markers for reed‐sternberg cells. A comparative study of peanut agglutinin, leu‐m1, ln‐2, and ber‐h2 (1989) (30)
Demonstration of identical clonal derivation in a case of “oculocerebral” lymphoma (2005) (30)
Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies. (1984) (30)
Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas. (2000) (30)
Aggressive B‐cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology (2005) (30)
Expression‐patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer (2003) (30)
Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T‐bet as positive markers (2013) (29)
The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer (2007) (29)
Detection of viral genomes in the liver by in situ hybridization using 35S-, bromodeoxyuridine-, and biotin-labeled probes. (1989) (29)
Three coexisting lymphomas in one patient: genetically related or only a coincidence? (2006) (29)
The Germinal Center: Morphology, Histochemistry, and Immunohistology (1982) (29)
Immunophenotyping of T-lymphoblastic lymphoma/leukemia: correlation with normal T-cell maturation. (1986) (29)
An investigation of Ki‐1 positive large cell lymphoma with antibodies reactive with tissue macrophages (1986) (28)
Nuclear Factor B – dependent Gene Expression Profiling of Hodgkin ’ s Disease Tumor Cells , Pathogenetic Significance , and Link to Constitutive Signal Transducer and Activator of Transcription 5 a Activity (2002) (28)
Differential expression of apoptosis, Bcl‐x and c‐Myc in normal and malignant lymphoid tissues (1997) (28)
Single and Double Immunoenzymatic Techniques for Labeling Tissue Sections with Monoclonal Antibodies a (1983) (28)
A new monoclonal antibody (CAL2) detects CALRETICULIN mutations in formalin-fixed and paraffin-embedded bone marrow biopsies (2015) (28)
Pathology of intestinal lymphomas. (2000) (28)
T-cell lymphomas. A cell origin-related classification on the basis of cytologic, immunologic, and enzyme cytochemical criteria. (1981) (28)
Rapid and Accurate Diagnosis of Human Intestinal Spirochetosis by Fluorescence In Situ Hybridization (2009) (27)
Monoclonal antibodies in diagnostic pathology: techniques and applications. (1983) (27)
Analysis of BCL-6 mutations in classic Hodgkin disease of the B- and T-cell type. (2001) (26)
Extranodal marginal zone B-cell lymphoma of the lacrimal gland associated with crystal-storing histiocytosis. (2002) (26)
Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma. (1997) (26)
Cutaneous involvement in prelymphomatous angioimmunoblastic lymphadenopathy. (1997) (26)
MORPHOLOGY, CYTOCHEMISTRY, AND IMMUNOHISTOLOGY OF T CELL LYMPHOMAS (1982) (26)
Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker (2005) (25)
Evidence of Sternberg-Reed cells being derived from activated lymphocytes. (1985) (25)
Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells. (1987) (25)
Receptor revision of immunoglobulin heavy chain genes in human MALT lymphomas (2003) (25)
Inflammatory pseudotumors of lymph node origin show macrophage- derived spindle cells and lymphocyte-derived cytokine transcripts without evidence of T-cell receptor gene rearrangements. Implications for pathogenesis and classification as an idiopathic retroperitoneal fibrosis-like sclerosing immune (1996) (25)
Report: workshop on mediastinal grey zone lymphoma (2005) (25)
Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. (1998) (24)
The distribution of CD10 (NEP 24.11, CALLA) in humans and mice is similar in non‐lymphoid organs but differs within the hematopoietic system: absence on murine T and B lymphoid progenitors (1995) (24)
Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria (2005) (24)
Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates (2004) (24)
Cutaneous T cell lymphoma and classic Hodgkin lymphoma of the B cell type within a single lymph node: composite lymphoma (2004) (24)
Secondary ocular involvement in systemic "memory" B-cell lymphocytic leukemia. (2001) (24)
Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon‐treated hairy cell leukaemia patients (1990) (24)
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL (2019) (24)
Jagged 1-induced Notch signaling drives proliferation of multiple myeloma cells (2004) (23)
EPSTEIN-BARR VIRUS/COMPLEMENT RECEPTOR AND EPITHELIAL CELLS (1989) (23)
Reactive and neoplastic human lymphoid cells producing J chain in the absence of immunoglobulin: evidence for the existence of 'J chain disease'? (1981) (23)
Common and HIV‐related diffuse large B‐cell lymphomas differ in their immunoglobulin gene mutation pattern (1999) (23)
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients (2018) (23)
An immunomorphometric study on megakaryocyte precursor cells in bone marrow tissue from patients with chronic myeloid leukemia (CML) (1990) (23)
Gene synthesis, expression in Escherichia coli and purification of immunoreactive human insulin-like growth factors I and II. Application of a modified HPLC separation technique for hydrophobic proteins. (1989) (23)
Photosensitive dermatitis with actinic reticuloid syndrome: an immunohistological study of the cutaneous infiltrate (1986) (23)
New anti-CD30 human pancreatic ribonuclease-based immunotoxin reveals strong and specific cytotoxicity in vivo (2007) (23)
Aberrant expression of the Th 2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT 3 signaling and attracts Treg cells via regulation of MIP-3 (2008) (22)
Expression of interleukin 2 receptor on Hodgkin's and non-Hodgkin's lymphomas and macrophages. (1985) (22)
Specificities of monoclonal antibodies B-ly7 and HML-1 are identical. (1990) (22)
Characterisation of adenoid cystic carcinoma of the breast by immunohistology. (1989) (22)
Different T‐bet expression patterns characterize particular reactive lymphoid tissue lesions (2006) (22)
Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification. (1978) (22)
Cerebral lymphoma in AIDS. Clinical, radiological, neuropathological and immunopathological study. (1991) (22)
Clonality of Reed-Sternberg cells in Hodgkin's disease. (1999) (22)
Intestinal T-cell lymphoma: a reassessment of cytomorphological and phenotypic features in relation to patterns of small bowel remodelling (1996) (22)
Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: An immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies (2005) (22)
Tumor cytokinetic response to total parenteral nutrition in patients with head and neck cancers. (1991) (22)
Activity and isoenzymes of acid phosphatase in human B‐cell lymphomas of low‐grade malignancy: A novel aid in the classification of malignant lymphoma (1980) (22)
Ig rearrangements in isolated Reed-Sternberg cells: conclusions from four different studies. (1996) (22)
Immunohistological analysis of human lymphoid tissue by double immunoenzymatic labelling (2004) (21)
Increased number of accessible sugar epitopes defined with monoclonal antibody AM-3 on colonic mucins is associated with malignant transformation of colonic mucosa. (1991) (21)
Identification of HLA‐A2‐restricted epitopes of the tumor‐associated antigen MUC2 recognized by human cytotoxic T cells (1998) (21)
Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. (1990) (21)
Tracheal transplantation. III. Demonstration of transplantation antigens on the tracheal mucosa of inbred rat strains (2004) (21)
Telomerase expression in uveal melanoma (2000) (20)
Peripheral T-cell lymphomas. (1991) (20)
Phenotypical characterization of the cells invading pancreatic islets of diabetic BB/OK rats: effect of interleukin 2 receptor‐targeted immunotherapy (1988) (20)
Regression of Epstein–Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet (2000) (20)
Lymphohistiocytic T‐cell lymphoma (1994) (20)
Cutaneous T-cell lymphoma severity index and T-cell gene rearrangement (1997) (20)
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC (2018) (20)
Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils. (1980) (20)
Immunoprecipitation of the interleukin‐2 receptor from Hodgkin's disease derived cell lines by monoclonal antibodies (1987) (20)
Common clonal T‐cell origin in a patient with T‐prolymphocytic leukaemia and associated cutaneous T‐cell lymphomas (2003) (20)
Prognostic value of nuclear survivin-expression in esophageal squamous cell carcinoma (2003) (20)
Hodgkin and Reed–Sternberg cells of classical Hodgkin's disease overexpress the telomerase RNA template (hTR) (1999) (20)
Follicular dendritic cells in non-Hodgkin lymphomas: localisation, characterisation and pathophysiological aspects. (1991) (20)
Identification of a chemokine receptor profile characteristic for mediastinal large B‐cell lymphoma (2009) (19)
Surgical therapy of gastrointestinal non-Hodgkin's lymphomas. (1996) (19)
The immune response to sporadic colorectal cancer in a novel mouse model (2010) (19)
LF61: a new monoclonal antibody directed against a trimeric molecule (150 kDa, 125 kDa, 105 kDa) associated with hairy cell leukaemia (1990) (19)
Nuclear and cytoplasmic distribution of cellular myb protein in human haematopoietic cells evidenced by monoclonal antibody. (1988) (19)
Megakaryocyte precursors (pro-and megakaryoblasts) in bone marrow tissue from patients with reactive thrombocytosis, polycythemia vera and primary (essential) thrombocythemia (1989) (19)
Testicular sex cord stromal tumour with granulosa cell differentiation: detection of steroid hormone receptors as a possible basis for tumour development and therapeutic management. (1990) (19)
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma (2019) (19)
Classical Hodgkin’s lymphoma shows epigenetic features of abortive plasma cell differentiation (2011) (18)
T-bet Transcription Factor Detection Facilitates the Diagnosis of Minimal Hairy Cell Leukemia Infiltrates in Bone Marrow Trephines (2007) (18)
Determination of proliferative activities in human brain tumor specimens: a comparison of three methods (1991) (18)
Vimentin expression of newly formed rat bile duct epithelial cells in secondary biliary fibrosis (2004) (18)
MONOCLONAL ANTIBODY (HML-1) LABELLING OF T-CELL LYMPHOMAS (1989) (18)
Discordant results obtained for different methods of HER-2/neu testing in breast cancer--a question of standardization, automation and timing. (2004) (18)
Thymic hyperplasia following chemotherapy of a testicular germ cell tumor. Immunohistological evidence for a simple rebound phenomenon (1989) (17)
Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma (2015) (17)
Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases (2019) (17)
Epstein-Barr virus infection in Western European pediatric non-Hodgkin lymphomas. (2003) (17)
Hodgkin's disease: update of findings. (1991) (17)
T‐bet expression patterns in coeliac disease, cryptic and overt enteropathy‐type T‐cell lymphoma (2005) (17)
Human papillomavirus infection is not associated with bronchial carcinoma: evaluation by in situ hybridization and the polymerase chain reaction. (1997) (17)
Hodgkin's disease: biology and origin of Hodgkin and Reed-Sternberg cells. (1999) (16)
SCL/Tal-1 expression in T-acute lymphoblastic leukemia: an immunohistochemical and genotypic study. (1995) (16)
Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype (2013) (16)
Oral lichen planus: diagnostic immunofluorescence testing on routine histological material (2003) (16)
Phenotypic and genotypic analysis of two cell lines derived from Hodgkin's disease tissue biopsies. (1989) (16)
The Epstein-Barr virus receptor is distinct from the C3 receptor. (1983) (16)
Three new types of Apaf-1 in mammalian cells. (1999) (16)
Personal points of view on the Kiel classification. (1978) (15)
Human Membrane‐bound C3 Receptors I. Serological and Immunohistological Demonstration of C3 Receptors (1981) (15)
Non‐mediastinal grey zone lymphomas and report from the workshop (2005) (15)
Clonal relationship between langerhans cell histiocytosis and myeloid sarcoma (2012) (15)
In situ hybridization using biotinylated probes. An evaluation of different detection systems. (1989) (15)
Evidence for B-cell origin of reticulum cell sarcoma (2005) (15)
Tumor viruses in CD30-positive anaplastic large cell lymphomas. (1993) (15)
Frequent presence of latent Epstein‐Barr virus infection in lymphoepithelioid cell lymphoma (Lennert's lymphoma) (1994) (15)
Precursor T-lymphoblastic lymphoma within a recurrent pituitary adenoma (2008) (15)
Presence of mature DC-Lamp+ dendritic cells in sentinel and non-sentinel lymph nodes of breast cancer patients. (2008) (15)
Hodgkin's disease and Epstein-Barr virus. (1992) (15)
Cell kinetics, morphology, and molecular IgVH gene rearrangements in Hodgkin's disease. (1997) (14)
Immunohistologic Analysis ofthe Organization of Normal Lymphoid Tissue and Non-Hodgkin's as'2 (1980) (14)
T-cell lymphomas of the stomach: Morphological and immunological studies characterizing two cases of T-cell lymphoma (2004) (14)
Relapse of primary extranodal marginal-zone B-cell lymphoma of the dura mater. (2005) (14)
T-cell growth factor receptor (Tac-antigen) expression in cutaneous lymphoid infiltrates. (1986) (14)
Proliferative pattern of head and neck cancer. (1991) (14)
Prognostic Value of Multimarker Analysis in Stage III Colorectal Cancer: One Step Forward Towards an Individualized Therapy Decision (2005) (14)
Megakaryocytopoiesis in bone marrow biopsies of patients with acquired immunodeficiency syndrome (AIDS). An immunohistochemical and morphometric evaluation with special emphasis on myelodysplastic features and precursor cells. (1992) (14)
IDH1-R132 changes vary according to NPM1 and other mutations status in AML (2019) (13)
Structure of the Hodgkin's lymphoma-associated human CD30 gene and the influence of a microsatellite region on its expression in CD30(+) cell lines. (2001) (13)
Primary dedifferentiated liposarcoma of the lung (2005) (13)
Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl–2 inhibitor HA14–1 (2004) (13)
Low‐grade non‐hodgkin's lymphoma after high‐grade non‐hodgkin's lymphoma in a child with ataxia teleangiectasia (1994) (13)
Analysis of single EBER‐positive and negative tumour cells in EBV‐harbouring B‐cell non‐Hodgkin lymphomas (2001) (13)
The restricted expression pattern of the Hodgkin's lymphoma‐associated cytokine receptor CD30 is regulated by a minimal promoter (2000) (13)
Upregulation of CD40 and CD40 ligand expression in IgE-associated cutaneous diseases. (1997) (13)
The impact of SOCS1 mutations in diffuse large B‐cell lymphoma (2019) (13)
Anti-CD30 human IL-2 fusion proteins display strong and specific cytotoxicity in vivo. (2009) (13)
Antiproliferative effect of human interleukin-4 in human cancer cell lines: studies on the mechanism. (1995) (13)
Identification of different laminin binding proteins in basolateral cell membranes of human colorectal carcinomas and normal colonic mucosa. (1991) (13)
Expression of several members of the TNF‐ligand and receptor family on tonsillar lymphoid B cells (1997) (13)
A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients. (2020) (13)
A 19-week-old fetus with craniosynostosis, renal agenesis and gastroschisis: case report and differential diagnosis. (1997) (13)
Expression of the intestinal T‐lymphocyte associated molecule HML‐1: analysis of 75 non‐Hodgkin's lymphomas and description of the first HML‐1 positive T‐lymphoblastic tumour (1991) (12)
Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells (2012) (12)
Polymerase Chain Reaction Analysis of t(14;18) Junctional Regions in B-Cell Lymphomas. (1990) (12)
Low incidence of mbr bcl‐2/JH fusion genes in Hodgkin's disease (1995) (12)
Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis (2016) (12)
A novel A20 (TNFAIP3) antibody (Ber‐A20) can be used to detect unmutated A20 by immunohistology (2012) (12)
Extranodal mantle cell lymphoma mimicking marginal zone cell lymphoma (2001) (12)
A Novel CD11c Monoclonal Antibody Effective in Formalin-Fixed Tissue for the Diagnosis of Hairy Cell Leukemia (2008) (11)
Physicochemical characterization of C3b receptors isolated from human erythrocytes by immunoprecipitation. (1980) (11)
AN IMMUNOHISTOCHEMICAL STUDY OF TAL‐1 PROTEIN EXPRESSION IN LEUKAEMIAS AND LYMPHOMAS WITH A NOVEL MONOCLONAL ANTIBODY, 2TL 242 (1996) (11)
Differential sensitivity of CD30+ neoplastic cells to gelonin delivered by anti‐CD30/anti‐gelonin bispecific antibodies (1995) (11)
Pro-megakaryoblasts in bone marrow tissue from patients with primary (idiopathic) osteo-myelofibrosis (agnogenic myeloid metaplasia). An immunomorphometric study on trephine biopsies. (1990) (11)
Primary Neuroendocrine Carcinoma of Inguinal Lymph Node (2005) (11)
Isoelectric focusing pattern of IgM and surface markers in non-Hodgkin's lymphomas. (1977) (11)
Histological features of prognostic significance in CML — an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow (1993) (11)
Expression of Functional GABAA Receptors in Isolated Human Insulinoma Cells (1998) (11)
Quantitative and qualitative differences in the distribution of HLA class I antigenic determinants in the human thymic compartments (1983) (11)
Molecular biology of Hodgkin's disease. (1997) (10)
T-cell clonality of undetermined significance. (2006) (10)
[Primary brain lymphoma in acquired immunodeficiency syndrome. Immunophenotype and molecular pathologic characterization in stereotactic biopsy, autopsy and cerebrospinal fluid cytology]. (1995) (10)
BRAFV600E mutations are found in Richter syndrome and may allow targeted therapy in a subset of patients (2015) (10)
Analysis of the tumor microenvironment by whole-slide image analysis identifies low B cell content as a predictor of adverse outcome in advanced-stage classical Hodgkin lymphoma treated with BEACOPP. (2020) (10)
The Differential Diagnosis of Routinely Processed Anaplastic Tumors Using Monoclonal Antibodies (1985) (10)
IMMUNOGLOBULIN V GENES IN REED-STEMBERG CELLS (1996) (10)
Macrophages (phagocytic-histiocytic reticular cells) in reactive-inflammatory lesions of the bone marrow and in myelodysplastic syndromes (MDS). An immunohistochemical and morphometric study by use of a new monoclonal antibody (PG-M1). (1992) (10)
IgM-producing malignant lymphomas without macroglobulinemia. Morphological and immunochemical findings (1973) (10)
Development and Differentiation of the T-Cell and B-Cell Systems: A Perspective (1980) (10)
[Proliferation marker Ki-67: correlation with histological diagnosis, neoplasm grading and clinical course]. (1986) (10)
Megakaryocyte precursors (promegakaryoblasts and megakaryoblasts) in the normal human bone marrow. An immunohistochemical and morphometric study on routinely processed trephine biopsies. (1990) (10)
Histopathology in the light of molecular profiling. (2006) (10)
[Use of immunocytochemistry in practical diagnosis by the pathologist. Areas of use--methods--cost planning]. (1984) (10)
Localized and Advanced Stage Follicular Lymphomas Differ in their Gene Expression Profiles. (2019) (9)
In situ immunological characterization of Langerhans cells with monoclonal antibodies: Comparison with other dendritic cells in skin and lymph nodes (2004) (9)
Acid alpha-naphthyl acetate esterase in hairy cell leukemia cells and other cells of the hematopoietic system (1979) (9)
Regulation of Mucin MUC2 Gene Expression during Colon Carcinogenesis (1998) (9)
Sequential versus alternating chemotherapy for high grade non‐hodgkin's lymphomas: A randomized multicentre trial (2006) (9)
Concordance of HER-2/neu expression of primary breast carcinomas and their metachronous distant metastases: results of a 10 year retrospective search in two university institutes of pathology (2004) (9)
Immunohistological analysis of Hodgkin's and Sternberg-Reed cells: Detection of a new antigen and evidence for selective IgG uptake in the absence of B cell, T cell and histiocytic markers (2004) (9)
A novel fusion of the MALT1 gene and the microtubule‐associated protein 4 (MAP4) gene occurs in diffuse large B‐cell lymphoma (2006) (9)
Normal and neoplastic Langerhans cells: phenotypic comparison with other types of macrophages. (1985) (9)
Multiple myeloma in a patient at risk for AIDS. (1990) (9)
Transition of Sézary syndrome into mycosis fungoides after complete clinical and molecular remission under extracorporeal photophoresis (2004) (9)
Immunoglobulin-production and surface-bound immunoglobulins in chronic lymphocytic leukemia, lymphosarcoma, and so-called reticulum cell sarcoma. (1974) (9)
The tale and molecular trail of a disseminated ocular adnexal malt lymphoma (2007) (9)
disease discovery Classification of lymphoid neoplasms: the microscope as a tool for (2008) (9)
The nature of Reed-Sternberg cells, lymphocytic and histiocytic cells and their molecular biology in Hodgkin’s disease. (1999) (9)
Immunologic markers in the differential diagnosis of non-Hodgkin's lymphomas (2004) (9)
Is Hodgkin's disease a unique entity? (1995) (9)
[Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)]. (1976) (8)
Clinical relevance of immunoglobulin mutation analysis (2000) (8)
To the Editor – Eur. J. Immunol. 1/2006 (2006) (8)
First Case Report of a Peripheral T-cell Lymphoma, not Otherwise Specified, of the Central Nervous System in a Child (2012) (8)
Presence of clonal T-cell receptor gene rearrangements provides evidence of widespread intramucosal intestinal T-cell lymphoma. (1996) (8)
Loss of Nuclear p 27 Expression and Its Prognostic Role in Relation to Cyclin E and p 53 Mutation in Gastroenteropancreatic NeuroendocrineTumors (2008) (8)
Unusual sites of Hodgkin's lymphoma: CASE 3. Cholemic nephrosis in Hodgkin's lymphoma with liver involvement. (2004) (8)
Cytogenetic findings in T-zone lymphoma (2004) (8)
Targeting of saporin to Hodgkin's lymphoma cells by anti‐CD30 and anti‐CD25 bispecific antibodies (1998) (8)
[Large B-cell lymphomas: variants and entities]. (2000) (8)
Cushing syndrome-associated pheochromocytoma and adrenal carcinoma. An immunohistological investigation. (1992) (8)
Human Membrane‐bound C3 Receptors (1981) (8)
[Eosinophilic granuloma of the temporal bone. Case report and literature review]. (2003) (7)
Surface markers on hairy cells. (1974) (7)
Demonstration of lysozyme, alpha 1-antichymotrypsin, alpha 1-antitrypsin, albumin, and transferrin with the immunoperoxidase method in lymph node cells. (1980) (7)
Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date (2009) (7)
Introduction to a review series: the 2016 revision of the WHO classi ﬁ cation of tumors of hematopoietic and lymphoid tissues (2016) (7)
Diagnosis of Hodgkin’s disease, Hodgkin’s-like anaplastic large cell lymphoma, and T cell/histiocyte-rich B cell lymphoma (1999) (7)
[Molecules of regulated secretion are differentiation markers of neuroendocrine tumors]. (1997) (7)
An immunohistological study of reactive lymphoid tissue (1983) (7)
Leiomyosarcoma of the kidney. Immunohistological and ultrastructural findings with special emphasis on the growth fraction. (1989) (7)
Expression of functional GABAA receptors in isolated human insulinoma cells. (1998) (6)
Hodgkin’s Disease and So-Called Malignant Histiocytosis: (1984) (6)
[Round robin test for detection of genomic aberrations in non-Hodgkin lymphoma by in situ hybridization]. (2013) (6)
Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP (2020) (6)
Is Hodgkin lymphoma just another B-cell lymphoma? (2009) (6)
Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP (2021) (6)
[Immunohistologic characterization of chordomas]. (1987) (6)
[Malignant lymphomas of the liver: new diagnostic algorithms]. (2006) (6)
Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression (2002) (6)
Tyrosine phosphorylation in human lymphomas (2004) (6)
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models. (2020) (6)
Epstein-Barr Virus Infection of Monocytoid B-Cell Proliferates: An Early Feature of Primary Viral Infection? (2005) (5)
Evolution of classic Hodgkin lymphoma in correlation to changes in the lymphoid organ structure of vertebrates. (2003) (5)
[2 cases of death following cell therapy]. (2008) (5)
Primary systemic anaplastic large cell lymphoma (ALCL) (1999) (5)
Lymph node plasmacytoma in a child: Clinical and immunological findings with special reference to S-Ig and complement receptor subtypes (1978) (5)
First non-imported HTLV-1 positive adult T cell leukemia/lymphoma (ATLL) in Germany (1999) (5)
Discordant Results Obtained for Different Methods of HER-2/Neu Testing in Breast Cancer – A Question of Standardization, Automation and Timing (2004) (5)
Targeting of type 1 ribosome-inactivating proteins to CD30+ or CD25+ hematologic neoplasias by bispecific antibodies. (1995) (5)
Improved grading of bone tumors with the monoclonal antibody Ki-67 (2004) (5)
Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue. (2012) (5)
2. Report on the Workshop: “Clinical Consequences of Pathology and Prognostic Factors in Aggressive NHL” (2001) (5)
Antisera with anti-pan C3 receptor reactivity which block complement C3b, C3bi and C3d receptors. (1982) (5)
Interferon-gamma and T-bet expression in a patient with toxoplasmic lymphadenopathy. (2010) (5)
[Immune reconstitution inflammatory syndrome (IRIS) of the small bowel in an immunocompromised patient suffering from systemic lupus erythematosus and non-tuberculous mycobacteriosis]. (2008) (5)
Reversed-phase high-performance liquid chromatography of very long oligodeoxyribonucleotides (1989) (5)
[The many faces of anaplastic large cell lymphoma]. (2000) (4)
Rapid Communication Transforming Growth Factors 1 and 2 Are Differentially Expressed in Fibrotic Liver Disease (2007) (4)
[Marginal zone lymphomas: extranodal MALT type, nodal and splenic]. (2000) (4)
[Clear cell chondrosarcoma (CCCS) of the nasal septum]. (2004) (4)
[Rare variants of cutaneous T-cell lymphomas]. (1996) (4)
T-Cell Neoplasia in the Perspective of Normal T-Cell Differentiation (1980) (4)
[Thymus carcinoid and mediastinal paraganglioma. Differential diagnosis and immunohistologic study]. (1989) (4)
Ultrastructural localization of human complement C3b receptors in the human kidney as determined by immunoperoxidase staining with the monoclonal antibody C3RTo5 (1982) (4)
High Serum Levels of Soluble Interleukin-2 Receptor and Absence of Detectable Levels of Soluble CD30 Molecule: A Specific Diagnostic Combination for Hairy Cell Leukemia (1992) (4)
Demonstration of intracytoplasmic immunoglobulin, lysozyme, and albumin and isoelectric focusing pattern of tissue immunoglobulin in so-called reticulum cell sarcoma (immunoblastic or large cell lymphoma). (1979) (4)
Immunoblastic morphology but not the immunohistochemical GCB/non-GCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL Running title: OUTCOME PREDICTION IN DLBCL (2010) (4)
Clonality and malignancy. PCR assays for the diagnosis of clonal B- and T-cell proliferations: potentials and pitfalls. (2003) (4)
Interleukin-4 inhibits growth of a human lung-tumor cell-line in-vitro and has therapeutic activity against xenografts of this cell-line in-vivo. (1993) (4)
Further characterization of the mucin antigen associated with malignant transformation of human colonic mucosa, detectable with the monoclonal antibody AM-3. (1990) (3)
Recent advances in the histopathology of stromal tumours of the endometrium (2005) (3)
Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma—a feasibility study using full slide staining (2018) (3)
[Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?] (2019) (3)
Immunopathology of non-Hodgkin lymphomas (1984) (3)
Results of a 10-year retrospective search in two university institutes of pathology: Concordance of HER-2/neu expression of primary breast carcinomas and their metachronous distant metastases (2004) (3)
[Primary pulmonary B-cell lymphoma of the MALT type]. (1995) (3)
The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl (2016) (3)
Monoclonal antibodies against the viral and human cellular myb gene product. (1987) (3)
Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas (2021) (3)
Evidence for the origin of Hodgkin and Sternberg-Reed cells from a newly detected small cell population. (1983) (3)
HUMAN PAPILLOMAVIRUS INFECTION IS NOT ASSOCIATED WITH BRONCHIAL CARCINOMA (1997) (3)
Monoclonal Antibodies: Characterization and Diagnosis of Malignant Lymphomas and Other Skin Neoplasms (1988) (3)
Myeloma producing nonsecretory IgM and secretory IgG. (2009) (3)
Anaplastic large cell lymphoma Hodgkin's like (1995) (3)
Distribution of human immunodeficiency virus (HIV) in the CNS of children with severe HIV encephalomyelopathy (2004) (3)
Presence of alpha1-antichymotrypsin and alpha1-antitrypsin in haematopoietic and lymphoid tissue cells as revealed by the immunoperoxidase method. (1980) (3)
[Hodgkin lymphoma. Classification and pathogenesis]. (2000) (2)
Benign and malignant lymphocytic skin infiltrates: immunological patterns recognized by immunohistochemical staining with monoclonal antibodies. (1985) (2)
[Comparison of the receptor content and growth fraction of breast cancers and their axillary lymph node metastases]. (1989) (2)
[Immunohistochemistry and morphometry of bone marrow in acquired immunodeficiency syndrome with special emphasis on megakaryopoiesis and macrophages]. (1991) (2)
A 62‐YEAR‐OLD MAN WITH CHRONIC PYOTHORAX (2005) (2)
[Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas]. (1991) (2)
Gushing Syndrome-Associated Pheochromocytoma and Adrenal Carcinoma (1992) (2)
CHOEP versus Alternating hCHOP/IVEP for High Grade Non-Hodgkin’s Lymphomas: A Randomized Multicentre Trial (1991) (2)
[Oral EBV-associated diffuse large B-cell lymphomas in HIV-negative immunocompromised patients]. (2006) (2)
Comments on Hodgkin's disease: the Sternberg-Reed cell by P. Bucsky (1988) (2)
[Small cell B-cell lymphomas: guidelines for differential diagnosis]. (2000) (2)
Aggressive B‑Zell-Lymphome (2019) (2)
[Aggressive B‑cell lymphomas : Recommendations from the German Panel of Reference Pathologists in the Competence Network on Malignant Lymphomas on diagnostic procedures according to the current WHO classification, update 2017]. (2019) (2)
[Classification of malignant non-Hodgkin lymphomas based on morpholigical and immunological characteristics of normal and neoplastic lymphatic cells]. (1976) (2)
Makroglobulinbildende chronische lymphatische Leukämie ohne Makroglobulinämie (1973) (2)
Results of a 10-year retrospective search in two university institutes of pathology: Concordance of HER-2/neu expression of primary breast carcinomas and their metachronous distant metastases. (2004) (2)
Screening for esophageal neoplasia in patients with head and neck cancer (2001) (2)
Immunohistological demonstration and physiochemical characterization of C3 receptors of normal and neoplastic lymphoid cells (2004) (2)
In vivo targeting of Hodgkin's and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2. Immunoscintigrafic and immunohistological evidence. (1992) (2)
Demonstration of C3 receptors on frozen sections of normal lymphoid tissue and malignant lymphomas using various EAC complexes (1980) (2)
Tumorous manifestation of hairy cell leukemia after long-term treatment with interferon alpha (1995) (2)
[Clinico-pathologic forms of peripheral T-and NK-cell lymphomas]. (2000) (2)
[2 unusual cutaneous T-cell lymphomas with extracutaneous involvement]. (1996) (1)
Malignant lymphomas in HIV-seropositive patients. Frequency, features, and prognosis. Report on 31 cases (1991) (1)
Response : Peripheral blood T-cell clonality of no cutaneous T-cell lymphoma diagnostic value (2001) (1)
[Monocytic B-cells represent a new cell population that is mainly recruited from unmutated polyconal naive B-cells]. (2000) (1)
The Prognostic Impact Of Gene Rearrangements and Protein Expression Of MYC, BCL2 and BCL6 In Young High-Risk Patients With DLBCL (2013) (1)
Intestinal intraepithelial T cell derived lymphoma not associated with enteropathy (1994) (1)
in Hodgkin and anaplastic large cell lymphoma Activated Notch1 signaling promotes tumor cell proliferation and survival (2013) (1)
[Coexpression of cytokeratin, desmin, and neurofilaments in malignant tumors]. (1988) (1)
[Immunological and immunochemical methods and their application in the classification of malignant non-Hodgkin's-lymphoma (author's transl)]. (1975) (1)
[Differentiation pathways of normal and malignant cells of the lymphatic system]. (1988) (1)
A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma. (2009) (1)
Mucosal Foxp3 + Regulatory T Cells Show Significant Numerical Differences in Patients with Intestinal Graft-Versus-Host Disease Compared to Infectious Diseases of the Gut. (2005) (1)
Conserved oncogenic module activation patterns (COMAPS) identify biologically homogeneous groups of diffuse large B-cell lymphomas and clearly define Burkitt lymphoma (2008) (1)
Molecular Weight Analysis of Human Complement (C3) Receptors Isolated by Immunoprecipitation (1982) (1)
Coexistence of spinal schwannoma with unusual malignant peripheral T-cell lymphoma within a lumbar spine lesion (2011) (1)
Detection of subclinical systemic disease in primary central nervous system lymphoma (PCNSL) by polymerase chain reaction (PCR) of the rearranged immunoglobulin heavy chain (IgH) genes. (2006) (1)
Definition of Burkitt Lymphoma (2013) (1)
[Lymphoid tissues and AIDS: role of lymphocytes and follicular dendritic cells (FDC)]. (1991) (1)
genetic, and clinical features CD30+ anaplastic large cell lymphoma: a review of its histopathologic, (2013) (1)
[Hodgkin's disease: the origin of HRS (Hodgkin and Reed-Sternberg) cells]. (1996) (1)
BCR-Assosiated Kinase Inhibition in Relapsed/Refractory Chronic Lymphocytic Leukemia. Real World Experiences of a German Regional Clinical Register (2020) (1)
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma (2019) (1)
The immunohistological analysis of undecalcified human bone marrow trephine biopsies. Technical and diagnostic aspects. (1984) (1)
L&H Cells in Lymphocyte-Predominant Hodgkin’s Disease – Reply to the letters to the Editor. (1998) (1)
A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (2018) (1)
Aurora kinases as novel drug targets in gastroenteropancreatic neuroendocrine tumor disease: Antiproliferative and pro-apoptotic effects of ZM 447439, a new aurora kinase inhibitor, in BON and QGP-1 cells (2008) (1)
[The significance of determining intermediate filament and epithelial membrane antigens in the differential diagnosis and histogenetic differentiation of ovarian tumors]. (1986) (1)
[Lymphatic system and differentiation of B and T lymphocytes]. (2000) (1)
Characterization of an IgG-Fc receptor protein isolated from human B-prolymphocytic and B-chronic lymphocytic leukemia cells. (1979) (1)
Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas (2022) (1)
[Hodgkin's disease: a mystery is being solved]. (1997) (1)
Evidence of Haematopoiesis within the Developing Human Diencephalon (2006) (1)
Inhibition of C3b and C3d receptor activity by xenoantisera prepared by immunization with cell-bound C3 receptor protein. (1979) (1)
[The morphologic variants of KSHV/HHV 8-associated lymphoproliferations]. (2007) (1)
Rapid Communication Follicular Dendritic Cells AreaMajor Reservoir forHumanImmunodeficiency Virus Type1inLymphoid Tissues Facilitating Infection ofCD4+ T-helper Cells (1992) (1)
Randomized , Double-Blind , Placebo-Controlled , Phase I 11 Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor as Adjunct to Induction Treatment of High-Grade Malignant Non-Hodgkin ' s Lymphomas (2003) (0)
Cervical intraepithelial neoplasia (CIN) and cervical carcinoma harbour highly increased numbers of Foxp3+ CD4+ CD25+ regulatory T-cells (2006) (0)
A modular transcriptome map of B-cell lymphomas (2019) (0)
Analysis of isolated, individual classical Hodgkin Lymphoma tumour cells on mutations in the mdm2 gene locus (2005) (0)
[Correlation of immunohistological results of stomach carcinomas with the Laurén classification and tumor stage]. (1986) (0)
Major Breakpoint Regions in Non-Hodgkin ' s Lymphomas Typed According to the Kiel Classification : Analysis by Direct DNA Sequencing 1 (2006) (0)
Clinicogenetic Risk Models in Patients Randomized to Receive Consolidative Autologous Stem-Cell Transplantation after Frontline R-CHOP for Advanced Follicular Lymphoma: An Analysis from the GLSG2000 Trial (2018) (0)
Moderate Number of Antigen-Selected Somatic Mutations (2007) (0)
[Pathomorphology of juvenile non-Hodgkin's lymphomas]. (1977) (0)
[The grading of invasive breast cancer according to Elston and Ellis]. (2007) (0)
Molecular weight analysis of Fcγ-binding proteins of lymphoid leukemia, myeloid leukemia, and hairy-cell leukemia (2004) (0)
Temporal and spatial patterns of transin/stromelysin RNA expression following CCL4-intoxication in rat liver (1991) (0)
Techniques for Characterization of Leucocyte Antigens and Utilization of Antibodies in Therapy (1984) (0)
Reviewing the ICD-10 classification of haematological neoplasms on its way to ICD-11 (2005) (0)
CD3 Mouse Monoclonal Antibodies, Assessment of the New Clone LN10 Against PS1: An Improvement on a Routine Tool for the Haematopathologist! (2007) (0)
HIV-related malignant lymphomas (1988) (0)
Immunophenotypicevidence for a close relationship between lymphomatoidpapulosis and Hodgkin's disease (1990) (0)
Rapid and accurate Diagnosis of Human Intestinal Spirochaetosis by Fluorescence in situ Hybridization 5 Running title : Intestinal spirochaetosis diagnosed by FISH (2009) (0)
Monocytoid B-cells represent a new cell population that mainly recruits from unmutated polyclonal naive B-cells (2000) (0)
Antigene lymphoide cd30 (1992) (0)
dissemination of neoplastic cells in lymphoid organs lymphocyte-predominant Hodgkin disease correlates with distinct Up-regulation of the chemokine receptor CCR7 in classical but not in (2014) (0)
[Proliferation of Reed-Sternberg cells in 5 Hodgkin's cell lines]. (1991) (0)
P-081 Detection of monocyte precursors in bone marrow biopsies for the differential diagnostic evaluation of chronic myelomonocytic leukemia by immunohistology (2013) (0)
Follicular Dendritic Cells Are a Major Reservoir for Human Immunodeficiency Virus Type 1 in Lymphoid Tissues Facilitating Infection of CD 4 + T-helper Cells (2007) (0)
Recombinant Human Interleukin 4 Has Antiproliferative Activity on Human Tumor Cell Lines Derived from Epithelial and Nonepithelial Histologies 1 (2006) (0)
young adults center-derived B-cell lymphoma affecting predominantly children and identify a subtype of germinal IRF4 Translocations activating (2013) (0)
(aLeu-M5) Allow the Diagnosis of Hairy Cell Leukemia (2017) (0)
Intestinal N on-Hodgkin's L ymphoma: A M ulticenter Prospective C linical S tudy F rom t he G erman S tudy G roup o n Intestinal N on-Hodgkin's L ymphoma (2003) (0)
[Atypical nuclear invaginations in a case of lymphoblastic lymphosarcoma (author's transl)]. (1973) (0)
Highproliferative activity ofReedSternberg associated antigen Ki- 1positive cells innormal lymphoid tissue (2011) (0)
Clonal T-cell composition detected by family specific polymerase chain reaction of the T-cell receptor beta chain is exclusively present in dilated cardiomyopathy (2003) (0)
Malignant lymphoma: current aspects in biology and classification (1997) (0)
Impaired Histone H3 Lysine 9 Methylation Accelerates Ras-Driven Lymphomagenesis by Disabling Cellular Senescence. (2004) (0)
Undulin gene expression in normal and fibrotic human liver (1991) (0)
Detection of genetic imbalances in human neuroendocrine tumors of the gut and the pancreas (1998) (0)
Further Characterization of a Molecule Associated with Gut Mucosa T Cells and Enteropathy-Associated Gut T Cell Lymphomas (1990) (0)
Relation between mycosis fungoides (MF) and Hodgkin's disease (HD) (1986) (0)
Recombinant Human Interleukin 4 Has Antiproliferative Activity on Human Tumor Cell Lines Derived from Epithelial and Nonepithelial Histologies1 (2006) (0)
Potent Chemoattractant for T Cells and Eosinophils Hodgkin/Reed-Sternberg Cells Induce Fibroblasts to Secrete Eotaxin, a (2013) (0)
Solid variant of angiomatoid fibrous histiocytoma masked by interstitial granuloma annulare in a 13-year-old child: no evidence for translocation breakpoints. (2014) (0)
analysis of lymphoid tissue . use in the immunohistological dendritic reticulum cells and its antibody reactive with human Production of a monoclonal (0)
immunotherapy factor receptor superfamily as a tool for diagnosis and CD 30 ( Ki-1 ) molecule : a new cytokine receptor of the tumor necrosis (2000) (0)
[Demonstration of surface IgM in blood lymphocytes using the immunoperoxidase method]. (1973) (0)
Consequences of perinatal suppression of T lymphocytes bearing T-cell receptor 2 in the fowl (1991) (0)
immunohistology . carcinoma of the breast by Characterisation of adenoid cystic (0)
Configuration of Ig in DNA from Sternberg-Reed cells (1995) (0)
Detection ofcytomegalovirus byinsitu hybridisation andimmunohistochemistry using newmonoclonal antibody CCH2:acomparison ofmethods (1988) (0)
[Expression of HLA-DR antigens (Ia-like antigens) in the cornea]. (1983) (0)
Differential expression of chemokine receptors in primary central nervous system and extracerebral lymphomas (2005) (0)
Somatic mutation in rearranged IgHV gene in various B-cell malignancies (1999) (0)
The Reed-Sternberg Cell and the CD30 Antigen (1995) (0)
Acid alpha naphthyl acetate esterase and beta-glucuronidase in hairy cell leukemia (2005) (0)
Epigenetic Transdifferentiation in Hodgkin Lymphoma (2005) (0)
Detection of Epstein-Barr Virus Genomes in Lymphoproliferative Diseases (1991) (0)
Book Reviews (2002) (0)
Potency of CD30 stimulation: analysis of anaplastic large cell lymphoma - and Hodgkin lymphoma cell lines (2005) (0)
[Demonstration of DNA tumor viruses in carcinomas of the upper respiratory tract]. (1990) (0)
Hodgkin Study Group (GHSG) lymphocyte-predominant Hodgkin lymphoma: a report from the German The prognostic impact of variant histology in nodular (2013) (0)
Identification of HLA-A2-restricted epitopes of the tumor-associated antigen MUC2 recognized by cytotoxic T-cells (1997) (0)
Inactivation of the Suv39h1 Histone Methyltransferase Accelerates Myc-Driven B-Cell Lymphomagenesis and Compromises Drug-Inducible Cellular Senescence. (2005) (0)
T-cell clonality of undetermined significance. Commentary and Authors' reply (2006) (0)
situ hybridization (see comments) positive anaplastic large cell lymphoma by combined Southern blot and in Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1- (2011) (0)
[Distribution of procollagen transcripts in chronic inflammatory bowel diseases using in situ hybridization]. (1991) (0)
endemic Burkitt lymphoma cell lines and primary tumors Gene-expression analysis identifies novel RBL2/p130 target genes in (2013) (0)
cells Novel markers of normal and neoplastic human plasmacytoid dendritic (2011) (0)
HML-1, an antibody raised against intestinal lymphocytes, recognises an antigen appearing on activated peripheral blood lymphocytes (1990) (0)
A modular transcriptome map of mature B cell lymphomas (2019) (0)
population-based prospective clinical trials Molecular profiling of pediatric mature B-cell lymphoma treated in (2008) (0)
demonstrates a common clonal T-cell origin Single-cell analysis of CD30+ cells in lymphomatoid papulosis (2013) (0)
Differences in Foxp3+ regulatory T cells in patients with intestinal graft-versus-host (GvH) disease, inflammatory bowel disease and infectious diseases (2005) (0)
[Immunochemical and immunocytological findings in non-Hodgkin's-lymphomas]. (1976) (0)
8700 Subclinical systemic disease and relapse pattern in primary central nervous system lymphoma (PCNSL) (2009) (0)
The peripheral benzodiazepine receptor: Clinical importance of up-regulation during human colorectal carcinogenesis and tumor spread (2005) (0)
Real Life Dates of Chronic Lymphocytic Leukemia (CLL) in Germany. Interim Analysis of 234 Consecutively New Diagnosed Patients in a German Epidemiological-Clinical Register (2018) (0)
[Endosonographic findings of benign and malignant lesions in the stomach wall. A prospective comparison with conventional imaging study procedures]. (1988) (0)
Human B Cell Lymphomas Studied with a Set of Monoclonal Antibodies Raised Against B Lymphoma Cells (1984) (0)
[Significance of lymphophagocytic infiltrates of breast cancers for lymph node metastasis]. (1985) (0)
Epstein-Barr virus mononucleosis: implications for the interindividual infection route of productively Epstein-Barr virus-infected cells in acute infectious Morphology, immunophenotype, and distribution of latently and/or (2011) (0)
Cytostatic Anticancer Drug Development: Preclinical Studies and Early Clinical Trials (1990) (0)
Central nervous system involvement in non-Hodgkin’s lymphoma: A single-center analysis of prognostic factors for survival (2005) (0)
Endomicroscopy in Acute Graft-versus-Host Disease (2008) (0)
[Malignant lymphomas expressing an epithelial membrane antigen. Value in the immunohistochemical diagnosis of tumors]. (1985) (0)
Detection ofhumanpapillomavirus type16DNA incarcinomas ofthepalatine tonsil (2011) (0)
14 T-Zell-Lymphome (2005) (0)
Classification : Analysis by Direct DNA Sequencing in Non-Hodgkin ' s Lymphomas Typed According to the Kiel (2006) (0)
Hodgkinʼs Disease Followed by Lymphomatoid Papulosis: Immunological Evidence Relating Both Conditions (1989) (0)
[Immunological demonstration of estrogen and progesterone receptors in testicular Leydig cell tumors]. (1988) (0)
[Comparison between differentiation status and growth behavior in colon carcinoma]. (1988) (0)
[Autopsy findings in patients with acquired immunodeficiency syndrome]. (1986) (0)
FOXP3+ Regulatory T-Cells (Tregs) in Conjunctival Naevi and Conjunctival Melanoma (2007) (0)
283 POSTER Apoptosis and cell cycle regulating proteins in gastroenteropancreatic neuroendocrine tumors: role of p27 (2006) (0)
GENE EXPRESSION PROFILE OF CYTOKINE AND CHEMO- KINE STATUS IN MICRODISSECTED PRIMARY HODGKIN AND REED-STERNBERG CELLS FOR NOVEL TAR- GETED THERAPY MOLECULAR CYTOGENETIC CHARACTERIZATION OF THE HODGKIN AND REED-STERNBERG CELLS IN CLASSICAL HODGKIN LYMPHOMA (2005) (0)
‘ ‘ focus on . . . ’ ’ session : profiling and prognosis (2008) (0)
lymphoma in Northeast Brazil Expression of Epstein-Barr virus-gene products in Burkitt's (2011) (0)
196 Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumour disease (2004) (0)
Apoptotic Lymphoma Cells Evoke a Pro-Senescent Stromal Signal That Limits Lymphoma Development. (2009) (0)
Prognosefaktoren unilateraler und bilateraler Mammakarzinome: Langzeit-Follow-Up bei 828 Patientinnen (2006) (0)
Fibrosis in Hodgkin's disease: fibrogenesis, fibrolysis, and factors contributing to their regulation (1995) (0)
resistant epitope BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol- (2011) (0)
[Considerations in Hodgkin's disease]. (1993) (0)
Immunoglobulin receptor evolution in follicular lymphoma and a review of literature (2007) (0)
Rapid and Accurate Diagnosis of Human Intestinal Spirochetosis by Fluorescence In Situ Hybridization (cid:1) (2009) (0)
3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL (2011) (0)
FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll FWlll CDRll (2002) (0)
[Demonstration of lysozyme in histiocytic reticulosarcoma and malignant reticulosis]. (1978) (0)
Classical H odgkin's D isease a nd F ollicular L ymphoma Originating F rom t he S ame G erminal C enter B C ell (1999) (0)
Mononucleosis in Nonimmunocompromised Individuals Strict Lymphotropism of Epstein-Barr Virus During Acute Infectious (2013) (0)
Corrigendum to “Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation” [Cancer Letters 168 (2001) 71–80] (2002) (0)
[Epstein-Barr virus associated lymphocyte proliferation]. (1992) (0)
Analysis of Clinico-Pathologic Features and Stromal Cell-Derived Factor (SDF)-1/CXCR4 in Myeloid Sarcoma (2008) (0)
For use in the diagnosis or therapy (2002) (0)
[Macroglobulin-producing chronic lymphocytic leukemia without macroglobulinemia]. (1973) (0)
[Primary ductal adenocarcinoma near the orbit]. (2010) (0)
Gene-expression analysis identifies novel RBL2/p130 (2007) (0)
Definition of germinal center cell-derived lymphomas by analysis of complement receptor subtypes and morphological criteria. (1979) (0)
ATM attenuates Myc-driven lymphomagenesis by sensing oncogene-induced DNA damage in vivo (2005) (0)
Elevated NF- (cid:1) B p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas (2005) (0)
Subject Index, Vol. 46, Supplement 2, 1990 (1990) (0)
[Fine structure of megakaryocyte precursor cells (promegakaryoblasts) derived from smears and sections of bone marrow tissue in patients with chronic myeloid leukemia and so-called primary osteomyelofibrosis with accompanying thrombocythemia]. (1990) (0)
gene rearrangements but defective immunoglobulin transcription originating from a germinal center B-cell with functional immunoglobulin Hodgkin and Reed-Sternberg cells represent an expansion of a single clone (2013) (0)
Megakaryocytes, erythropoietic and granulopoietic cells express CAL2 antibody in myeloproliferative neoplasms carrying CALR gene mutations (2019) (0)
Activating Transcription Factor 3 (ATF3) Is Overexpressed in Classical Hodgkin Lymphoma and Is Required for Survival of Hodgkin and Reed-Sternberg Cells in Response to Cellular Stress. (2004) (0)
HTLV-1 Proviral Sequences in Cutaneous CD30-Positive T Large Cell Lymphomas (1994) (0)
C-myc and c-H-ras RNA expression in rat liver following intoxication with CC14 (1989) (0)
Testicular sexcordstromal tumourwith granulosa cell differentiation: detection ofsteroid hormone receptors asapossible basis fortumour development andtherapeutic management (2011) (0)
[Epstein-Barr virus and malignant lymphomas--studies on incidence and localization of viral DNA]. (1990) (0)
LETTER TO THE EDITOR. Monokine expresion in Langerhans' cell histiocytosis. Author's reply (1997) (0)
Immunologische Unterschiede in Sentinel und Non-sentinel Lymphknoten unter Berücksichtigung des Metastasierungsausmaßes Immunologic differences in Sentinel and Non-sentinel lymph nodes in relation to the extent of lymphatic tumor involvement (2007) (0)
[Incidence of class D and E immunoglobulins in malignant lymphoma]. (1975) (0)
Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas B p50 complex formation and Bcl-3 expression in classical κ (2013) (0)
Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD (2014) (0)
The precise diagnosis of malignant B-cell lymphoproliferations (0)
834-2 Clonal T-cell composition is not associated with enteroviral or adenoviral infection in dilated cardiomyopathy: Implications for the pathogenesis of dilated cardiomyopathy (2004) (0)
[B-cell lymphomas (non-Hodgkin's lymphomas of B type) in children--morphologic and immunologic spectrum]. (1982) (0)
Subject Index, Vol. 46, Supplement 2, 1990 (1990) (0)
and chronic GvHD regulatory T cells are numerically deficient in acute + Mucosal FOXP3 (2011) (0)
of angioimmunoblastic lymphadenopathy type Patterns of cytokine gene expression in peripheral T-cell lymphoma (2011) (0)
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α Short title: IL-21 signaling in Hodgkin lymphoma (2013) (0)
rearrangement and somatic mutations in the VH genes Hodgkin's disease with a B-cell phenotype often shows a VDJ (2011) (0)
Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL) (2021) (0)
[Phenotypic and genotypic marker in malignant lymphomas: cellular origin of Hodgkin's disease and malignant histiocytosis as well as implications for classifying T-cell and B-cell lymphomas]. (1986) (0)
Session 12 : lymphoma and apoptosis (2011) (0)
Inactivation of the Myc−Induced DNA Damage Response Promotes Lymphomagenesis and Treatment Resistance In Vivo. (2006) (0)
MONOKINE EXPRESSION IN LANGERHANS' CELL HISTIOCYTOSIS. AUTHOR'S REPLY (1997) (0)
mucosal tissue integrity CCR7 deficiency causes ectopic lymphoid neogenesis and disturbed (2013) (0)
David York Mason (1941-2008). Antibody wizard and a founder of modern hemopathology (2008) (0)
A 78‐Year‐Old Male with a Right Occipital Lesion (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Harald Stein?

Harald Stein is affiliated with the following schools:

Harald Stein's Academic­Influence.com Rankings

Why Is Harald Stein Influential?

Harald Stein's Published Works

Published Works

What Schools Are Affiliated With Harald Stein?

Harald Stein's AcademicInfluence.com Rankings